sever
fever
thrombocytopenia
syndrom
sft
emerg
infecti
diseas
caus
sever
fever
thrombocytopenia
bunyaviru
sftsv
identifi
recent
multipl
provinc
china
sftsv
infect
mainli
tick
sting
also
infect
contact
blood
secret
sft
patient
sftsv
novel
phleboviru
within
bunyaviru
famili
damag
cell
tissu
wide
sft
acut
ill
clinic
present
abrupt
fever
thrombocytopenia
leukocytopenia
gastrointestin
symptom
neural
disord
proteinuria
hematuria
bleed
tendenc
case
fatal
rate
sever
diseas
howev
pathogen
mechan
patient
sftsv
infect
still
unclear
viral
interact
innat
immun
system
play
core
role
determin
outcom
infect
author
found
sft
patient
least
partli
immunemedi
might
play
import
role
determin
sever
clinic
outcom
lymphocyt
play
import
role
induct
cellular
immun
organ
dysfunct
lymphocyt
subset
caus
immunofunct
abnorm
made
diseas
deterior
progress
protractedli
lymphocyt
could
stimul
organ
produc
immun
respons
viral
antigen
organ
infect
sftsv
clear
mani
virus
encod
specif
gene
product
antagon
immun
respons
recent
year
therefor
figur
sftsv
interact
host
immun
system
essenti
understand
molecular
mechan
sft
recent
immunofunct
lymphocyt
subpopul
studi
respect
sftsv
infect
insuffici
analyz
tcell
subgroup
possibl
role
sft
diseas
present
studi
part
studi
pathogenet
mechan
sft
diseas
involv
admit
sft
patient
age
year
depart
infecti
diseas
union
hospit
tongji
medic
colleg
huazhong
univers
scienc
technolog
may
septemb
viral
rna
sft
sampl
detect
confirm
posit
sftsv
infect
use
certif
realtim
polymeras
chain
reaction
rtpcr
kit
serum
sampl
healthi
volunt
neither
suffer
diseas
take
medicin
recent
week
normal
control
divid
sft
patient
differ
group
base
consist
clinic
featur
serum
sampl
acut
phase
patient
collect
initi
week
week
recoveri
phase
mild
sever
case
serum
sampl
collect
around
day
post
onset
ill
accord
patient
condit
human
sampl
involv
studi
approv
research
ethic
committe
tongji
medic
colleg
huazhong
univers
scienc
technolog
written
inform
consent
sign
seri
blood
sampl
particip
peripher
venipunctur
drawn
ethylen
diamin
tetraacet
acid
edta
anticoagul
tube
immedi
sent
laboratori
peripher
blood
sampl
process
analysi
lymphocyt
subset
flow
cytometri
within
h
lymphocyt
subset
identifi
follow
monoclon
antibodi
cell
suspens
incub
dark
place
room
temperatur
min
red
blood
cell
remov
use
lysi
buffer
dark
place
room
temperatur
min
final
cell
wash
resuspend
phosphatebuff
salin
pb
got
result
flow
cytomet
fac
becton
dickison
crop
total
event
collect
per
sampl
lymphocyt
popul
select
gate
lymphocyt
number
posit
cell
includ
express
lymphocyt
b
cell
nk
cell
analyz
percentag
cell
lymphocyt
gate
differ
two
group
analyz
pair
student
test
p
valu
consid
statist
signific
use
twosid
comparison
confid
level
data
state
mean
sd
median
analys
perform
use
graphpad
prism
graph
pad
prism
la
jolla
ca
usa
record
clinic
cours
laboratori
data
sft
patient
prospect
thirtyfour
sft
patient
admit
hilli
mountain
area
hubei
henan
provinc
describ
histori
field
exposur
within
week
ill
onset
mean
age
year
rang
year
male
patient
suffer
fever
diseas
progress
mean
day
day
rang
day
mean
time
hospit
stay
day
rang
day
three
femal
patient
year
old
die
sever
sft
owe
oral
infect
lung
infect
fungu
staphylococcu
research
howev
sft
patient
die
heart
respiratori
failur
initi
sever
hour
hospit
get
sampl
among
patient
patient
acut
phase
includ
femal
male
averag
age
year
patient
sever
includ
femal
male
averag
age
year
tabl
take
account
factor
age
found
patient
two
stage
elderli
confirm
age
signific
predictor
multipl
organ
dysfunct
syndrom
mod
death
also
observ
set
clinic
laboratori
paramet
includ
hematolog
biochem
paramet
tabl
sft
patient
thrombocytopenia
decreas
wbc
ne
ly
alb
alt
ast
ldh
pt
ck
ckmb
elev
acut
phase
sever
sft
patient
acut
phase
sft
patient
indic
patient
first
week
onset
clinic
featur
laboratori
paramet
abnorm
comparison
sft
patient
recoveri
phase
serum
level
wbc
plt
ast
ck
significantli
lower
acut
phase
level
ne
ly
alt
alb
crp
bun
ldh
pt
show
statist
signific
sever
sft
case
categor
least
one
follow
symptom
respiratori
renal
hepat
cardiovascular
central
nervou
system
cn
dysfunct
even
system
inflammatori
respons
syndrom
sir
dissemin
intravascular
coagul
dic
tendenc
shock
signific
differ
serum
level
plt
ast
ck
ldh
sever
mild
case
p
death
case
alb
signific
differ
might
due
compar
small
studi
group
big
error
thirtyfour
sampl
sft
patient
healthi
donor
subject
flow
cytometri
immunofunct
test
valu
tlymphocyt
subpopul
b
cell
nk
cell
shown
fig
lymphocyt
decreas
significantli
sft
p
p
respect
sft
patient
significantli
higher
percentag
nk
cell
peripher
blood
p
compar
normal
control
proport
cell
b
cell
cell
also
diminish
elev
sft
patient
howev
obviou
statist
signific
sft
normal
control
regard
valu
cell
b
cell
cell
p
accord
clinic
manifest
result
auxiliari
examin
divid
sft
differ
group
level
includ
acut
convalesc
case
mild
sever
sft
death
surviv
sftsv
infect
compar
level
lymphocyt
patient
acut
convalesc
case
patient
mild
sever
sftsv
infect
patient
death
surviv
sft
respect
differ
signific
p
tlymphocyt
level
patient
acut
convalesc
case
patient
mild
sever
sftsv
infect
patient
death
surviv
sft
respect
differ
signific
p
proport
nk
cell
significantli
increas
patient
acut
phase
sever
sft
compar
convalesc
case
mild
sft
vs
vs
howev
within
sever
sft
patient
proport
b
cell
significantli
diminish
surviv
case
compar
death
case
vs
although
level
cell
cell
lower
sft
group
acut
phase
sever
sftsv
infect
control
group
convalesc
phase
mild
sftsv
infect
differ
signific
p
order
acquir
overal
comprehens
immunofunct
also
statist
compar
variat
lymphocyt
level
progress
diseas
pair
sampl
chosen
acut
convalesc
phase
among
sft
patient
well
pair
sampl
mild
sever
sftsv
infect
analysi
show
express
level
convalesc
phase
increas
near
normal
level
fig
level
nk
cell
convalesc
phase
decreas
compar
acut
phase
contrast
condit
sft
patient
progress
mild
sever
content
diminish
gradual
impress
level
elev
nk
cell
present
sever
sft
patient
fig
dynam
analys
indic
immunofunct
back
physiolog
rang
associ
recoveri
mild
state
sft
diseas
pathogenesi
sft
distinct
present
describ
clinic
symptom
laboratori
paramet
complet
cours
sft
diseas
characterist
obviou
patient
acut
phase
sever
sft
recoveri
phase
mild
sft
physiolog
balanc
laboratori
paramet
substanti
alter
acut
phase
return
physiolog
rang
recoveri
phase
shown
innat
immun
respons
determin
pathogenesi
sft
well
high
level
viral
replic
amount
lymphocyt
subset
stabl
rel
peripher
blood
tissu
lymphocyt
produc
moder
immun
respons
could
elimin
foreign
antigen
without
injur
intracorpor
organ
balanc
broken
sftsv
invad
amount
lymphocyt
subpopul
chang
studi
show
express
level
lymphocyt
subset
abnorm
peripher
blood
sft
especi
acut
phase
sever
sft
patient
prospect
studi
strike
find
signific
elev
nk
cell
distinct
depress
peripher
blood
patient
sftsv
infect
leukocyt
count
sft
less
averag
level
proport
lymphocyt
decreas
acut
sever
sft
patient
togeth
data
found
activ
cell
play
crucial
role
pathophysiolog
sft
sinc
main
proport
lymphocyt
peripher
blood
chang
total
number
cell
sft
patient
decreas
significantli
declin
number
lymphocyt
prompt
number
activ
cell
insuffici
particip
cellular
immun
respons
cellular
immun
function
low
sft
patient
express
cell
obvious
reduc
sft
made
function
immun
globulin
downgrad
time
also
found
percentag
nk
cell
significantli
high
well
known
nk
cell
classifi
lymphocyt
basi
morpholog
express
lymphoid
marker
common
origin
nk
cell
shown
human
mice
particip
earli
control
viru
infect
nk
cell
could
kill
viral
infect
transform
cell
therefor
nk
cell
highli
import
pathogenesi
sft
diseas
progress
reveal
studi
variat
lymphocyt
subpopul
associ
phase
diseas
patient
condit
acut
phase
leukocyt
count
less
gradual
return
normal
level
convalesc
phase
leukocyt
count
mild
sft
patient
less
sever
sftsv
infect
percentag
significantli
lower
acut
phase
sever
sftsv
infect
recoveri
phase
mild
sftsv
infect
balanc
immunocyt
broken
lymphocytopenia
took
place
due
effect
multipl
stimuli
li
et
al
found
lymphocyt
sharp
declin
research
sever
acut
respiratori
syndrom
ard
result
damag
cellular
immun
function
lymphocyt
could
induc
viru
specif
cytotox
cell
form
specif
polyclon
immun
assist
b
cell
produc
neutral
antibodi
made
key
role
incub
period
acut
phase
viru
infect
presum
reason
reduct
cell
acut
sever
sft
follow
firstli
lymphocyt
struggl
sftsv
avoid
fierc
injuri
organ
secondli
complic
immun
made
lymphocyt
damag
weaken
abil
immun
respons
urgent
condit
diseas
contrast
cell
found
count
nk
cell
show
increas
differ
statist
signific
acut
sever
case
nk
cell
compon
innat
immun
defens
could
directli
induc
death
virusinfect
cell
absenc
specif
immun
cellular
immun
nk
cell
possess
immunoregulatori
function
sinc
secret
cytokin
gcsf
inflammatori
cytokin
chemokin
play
role
pathogenesi
viru
infect
level
relat
sever
ill
simultan
nk
cell
might
exacerb
diseas
releas
multipl
inflammatori
cytokin
chemokin
damag
affect
tissu
direct
cytotox
found
level
increas
fatal
sft
case
could
induc
apoptosi
lymphocyt
might
one
possibl
mechan
lymphocytopenia
sft
patient
due
direct
indirect
attack
sftsv
therefor
infer
nk
cell
educ
main
role
sftsv
infect
cellular
immun
function
weaken
obvious
howev
indic
would
rise
obvious
recoveri
phase
prompt
temporari
cell
immunosuppress
result
sftsv
infect
express
cell
three
death
case
older
sever
sft
diminish
sharpli
moreov
sft
diseas
develop
level
leukocyt
count
progress
diminish
signific
declin
express
cell
posit
cell
lymphocyt
sftsv
trigger
immun
system
mechan
mainli
stimul
cell
produc
immun
respons
virus
deng
et
al
demonstr
sftsv
activ
mainli
immun
respons
viral
invas
declin
lymphocyt
caus
suppress
immunofunct
might
aggrav
patient
condit
time
found
percentag
b
cell
death
case
significantli
higher
surviv
case
might
indic
humor
immun
could
activ
patient
condit
extrem
seriou
humor
immun
produc
antibodi
develop
neutral
enhanc
phagocytosi
immunofunct
extrem
low
sever
sft
increas
risk
secondari
infect
howev
differ
lymphocyt
subgroup
might
help
judg
prognosi
death
surviv
owe
higher
variat
lower
case
number
conclus
lymphocyt
significantli
lower
sft
normal
control
damag
cellular
immun
system
obviou
diseas
progress
patient
sftsv
infect
nk
cell
significantli
higher
play
import
role
kill
viral
infect
cell
furthermor
immunofunct
damag
serious
sever
sft
patient
acut
phase
therefor
immunofunct
detect
might
indic
aid
physician
evalu
diseas
sever
sft
patient
